Filing Details
- Accession Number:
- 0001567619-18-002682
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-14 19:27:16
- Reporting Period:
- 2018-09-12
- Accepted Time:
- 2018-09-14 19:27:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1435049 | Aduro Biotech Inc. | ADRO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1465994 | Jennifer Lew | C/O Aduro Biotech, Inc. 740 Heinz Avenue Berkeley CA 94710 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-09-12 | 67,825 | $0.00 | 141,813 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2018-09-13 | 5,623 | $6.50 | 136,190 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from the grant date of September 12, 2018.
- The shares were sold to cover the tax obligation that occurred upon the vesting of RSUs.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.25 to $6.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Billionaire Hedge Funds
